by Pete Celano | Aug 5, 2025 | Uncategorized
End stage liver disease (ESLD), also known as the final stage liver failure, is an irreversible liver condition that occurs due to acute liver failure or chronic liver diseases resulting in disruption of hepatic parenchyma (liver cells) and the adjacent structures...
by Pete Celano | Aug 4, 2025 | Uncategorized
This 30 July 2025 Gut article “Thrombospondin‑2 is a performant biomarker of at‑risk MASH and advanced MASH fibrosis in a large multicentre European cohort” is revealing; a snapshot of the future. 🧠 Background & Objective Clinical need exists for non‑invasive,...
by Pete Celano | Jul 27, 2025 | Uncategorized
Here’s a summary of the ContagionLive article “Non‑Targeted Hepatitis C Screening in Emergency Departments Increases Diagnoses” (published July 21, 2025): 🧬 Findings from the DETECT Hep C Trial 1. Study Design & Rationale The DETECT Hep C trial was a large...
by Pete Celano | Jul 25, 2025 | Uncategorized
Progressive familial intrahepatic cholestasis (PFIC) is a rare genetic disorder that causes severe itchiness and liver failure. Patients with PFIC develop liver failure as a result of a buildup of a digestive fluid known as bile. PFIC is a group of rare genetic...
by Pete Celano | Jul 18, 2025 | Uncategorized
At the core of diagnosing — and surveilling longitudinal care — is the FIB-4, from a standard CBC aka Complete Blood Count (bloodwork), from a venipuncture e.g., at Quest or Labcorp.This is irrespective of fast-rising Transient Liver Elastography, a...
